Phosphatidylinositol 3 kinase (PI3K)-AKT [18, 19] and ERK1/2 [20] pathways is frequently activated in human cancer, exerting growth-promoting, metastasis-promoting and antiapoptotic activities in tumor cells. The gene discussed is MAPK3; the disease is neoplasm.